Wednesday, May 04, 2022 Dr. Jonathan Loree has been recognized for his Phase III research contributions with the CCTG 2022 Dr. Ralph Meyer Phase III Young Investigator Award. Dr. Loree is a GI medical oncologist at BC Cancer and Assistant Professor at the University of British Columbia. He completed medical school and internal medicine at the University of Alberta before moving to British Columbia for his medical oncology fellowship. He then undertook a translational research fellowship at MD Anderson Cancer Center before returning to work on staff at BC Cancer. He is the CCTG Colon Cancer Disease Site Co-chair, a member of the IND Executive Committee, leads the BC Cancer GI Clinical Trials Unit and his research focus is biomarker development in colorectal cancer and neuroendocrine neoplasms. “It’s an honor to be considered for this award. I’ve had tremendous opportunities and mentorship afforded to me while working with the CCTG and I am incredibly grateful for all of those experiences. Thank you to everyone at CCTG for creating such an amazing environment for young investigators.”
